1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis
(
- Contribution to journal › Article
- 2010
-
Mark
A Missense Mutation in the Aggrecan C-type Lectin Domain Disrupts Extracellular Matrix Interactions and Causes Dominant Familial Osteochondritis Dissecans
(
- Contribution to journal › Article
- 2007
-
Mark
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials
(
- Contribution to journal › Article
- 1996
-
Mark
Increased concentrations of bone sialoprotein in joint fluid after knee injury
(
- Contribution to journal › Article
- 1995
-
Mark
Authors' reply
(
- Contribution to journal › Article
- 1994
-
Mark
Cartilage metabolism in the injured and uninjured knee of the same patient
(
- Contribution to journal › Article
-
Mark
Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis
(
- Contribution to journal › Article
- 1992
-
Mark
Proteoglycan fragments in joint fluid : Influence of arthrosis and inflammation
(
- Contribution to journal › Article
- 1989
-
Mark
Increased levels of proteoglycan fragments in knee joint fluid after injury
(
- Contribution to journal › Article
- 1978
-
Mark
Cartilage proteoglycan aggregates. Electron-microscopic studies of native and fragmented molecules
(
- Contribution to journal › Article